查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386409

胞外體治療市場報告：2030 年趨勢、預測與競爭分析

Exosome Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

胞外體治療的趨勢和預測

預計到 2030 年，全球胞外體治療市場將達到 18 億美元，2024 年至 2030 年年複合成長率為 25.7%。這個市場的主要驅動力是人們胞外體療法潛力的認知不斷提高、政府加大胞外體療法開發和商業化的支持以及全球慢性病盛行率的上升。全球胞外體治療市場的未來充滿希望，研究和學術機構以及醫院和診斷中心市場存在機會。

胞外體治療市場洞察

Lucintel 預測，在預測期內，天然外吐小體將繼續成為最大的細分市場，因為它們比混合外吐小體更豐富、更容易製造、更俱生物相容性並且保存期限更長。

由於胞外體治療研究的高需求，預計研究和學術機構將繼續佔據該市場的很大一部分。

由於其強大的研發基礎設施和有利的法規環境，北美仍然是我們最大的市場。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球胞外體治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球胞外體治療市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球胞外體治療市場
    • 天然胞外體
    • 混合胞外體
  • 全球胞外體治療市場（按應用）
    • 代謝紊亂
    • 腫瘤學
    • 心臟病
    • 神經病學
    • 發炎疾病
    • 器官移植
    • 婦科疾病
    • 血液疾病
    • 其他
  • 全球胞外體治療市場（依最終用途）
    • 研究和學術機構
    • 醫院和診斷中心

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球胞外體治療市場（按地區）
  • 北美胞外體治療市場
  • 歐洲胞外體治療市場
  • 亞太胞外體治療市場
  • 其他區域胞外體治療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球胞外體治療市場成長機會
    • 全球胞外體治療市場成長機會（按應用）
    • 全球胞外體治療市場成長機會（依最終用途）
    • 按地區分類的全球胞外體治療市場成長機會
  • 全球胞外體治療市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球胞外體治療市場的產能
    • 全球胞外體治療市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Church & Dwight
  • GSK
  • Pfizer
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • F. Hoffmann-La Roche
  • CELGENE Corporation
簡介目錄

Exosome Therapeutics Trends and Forecast

The future of the global exosome therapeutics market looks promising with opportunities in the research & academic institute and hospital & diagnostic center markets. The global exosome therapeutics market is expected to reach an estimated $1.8 billion by 2030 with a CAGR of 25.7% from 2024 to 2030. The major drivers for this market are increasing awareness towards the potential of exosome therapeutics, growing government supports for development and commercialization of exosome therapeutics, and rising prevalence of chronic diseases across the globe.

A more than 150-page report is developed to help in your business decisions.

Exosome Therapeutics by Segment

The study includes a forecast for the global exosome therapeutics by type, application, end use, and region.

Exosome Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Natural Exosome
  • Hybrid Exosome

Exosome Therapeutics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Metabolic Disorders
  • Oncology
  • Cardiac Disorders
  • Neurology
  • Inflammatory Disorders
  • Organ Transplantation
  • Gynecology Disorders
  • Blood Disorders
  • Others

Exosome Therapeutics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Research & Academic Institutes
  • Hospitals & Diagnostic Centers

Exosome Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Exosome Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies exosome therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the exosome therapeutics companies profiled in this report include-

  • Church & Dwight
  • GSK
  • Pfizer
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • F. Hoffmann-La Roche
  • Celgene Corporation

Exosome Therapeutics Market Insights

Lucintel forecasts that natural exosome will remain the largest segment over the forecast period due to as more abundant, easier to produce, more biocompatible, and have a longer shelf life than hybrid exosomes.

Within this market, research and academic institutes is expected to remain the larger segment due to high demand for exosome therapeutics research.

North America will remain the largest region due to well-funded research and development infrastructure and the favorable regulatory environment in the region.

Features of the Global Exosome Therapeutics Market

Market Size Estimates: Exosome therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Exosome therapeutics market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Exosome therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the exosome therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the exosome therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the exosome therapeutics market size?

Answer: The global exosome therapeutics market is expected to reach an estimated $1.8 billion by 2030.

Q.2 What is the growth forecast for exosome therapeutics market?

Answer: The global exosome therapeutics market is expected to grow with a CAGR of 25.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the exosome therapeutics market?

Answer: The major drivers for this market are increasing awareness towards the potential of exosome therapeutics, growing government supports for development and commercialization of exosome therapeutics, and rising prevalence of chronic diseases across the globe.

Q4. What are the major segments for exosome therapeutics market?

Answer: The future of the exosome therapeutics market looks promising with opportunities in the research & academic institute and hospital & diagnostic center markets.

Q5. Who are the key exosome therapeutics market companies?

Answer: Some of the key exosome therapeutics companies are as follows:

  • Church & Dwight
  • GSK
  • Pfizer
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • F. Hoffmann-La Roche
  • Celgene Corporation

Q6. Which exosome therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that natural exosome will remain the larger segment over the forecast period as it is abundant in nature, more biocompatible, and possess a longer shelf life than hybrid exosomes.

Q7. In exosome therapeutics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to well-funded research and development infrastructure and the favorable regulatory environment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the exosome therapeutics market by type (natural exosome and hybrid exosome), application (metabolic disorders, oncology, cardiac disorders, neurology, inflammatory disorders, organ transplantation, gynecology disorders, blood disorders, and others), end use (research & academic institutes and hospitals & diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Exosome Therapeutics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Exosome Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Exosome Therapeutics Market by Type
    • 3.3.1: Natural Exosome
    • 3.3.2: Hybrid Exosome
  • 3.4: Global Exosome Therapeutics Market by Application
    • 3.4.1: Metabolic Disorders
    • 3.4.2: Oncology
    • 3.4.3: Cardiac Disorders
    • 3.4.4: Neurology
    • 3.4.5: Inflammatory Disorders
    • 3.4.6: Organ Transplantation
    • 3.4.7: Gynecology Disorders
    • 3.4.8: Blood Disorders
    • 3.4.9: Others
  • 3.5: Global Exosome Therapeutics Market by End Use
    • 3.5.1: Research & Academic Institutes
    • 3.5.2: Hospitals & Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Exosome Therapeutics Market by Region
  • 4.2: North American Exosome Therapeutics Market
    • 4.2.2: North American Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
  • 4.3: European Exosome Therapeutics Market
    • 4.3.1: European Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
    • 4.3.2: European Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
  • 4.4: APAC Exosome Therapeutics Market
    • 4.4.1: APAC Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
    • 4.4.2: APAC Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
  • 4.5: ROW Exosome Therapeutics Market
    • 4.5.1: ROW Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
    • 4.5.2: ROW Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Exosome Therapeutics Market by Type
    • 6.1.2: Growth Opportunities for the Global Exosome Therapeutics Market by Application
    • 6.1.3: Growth Opportunities for the Global Exosome Therapeutics Market by End Use
    • 6.1.4: Growth Opportunities for the Global Exosome Therapeutics Market by Region
  • 6.2: Emerging Trends in the Global Exosome Therapeutics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Exosome Therapeutics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Therapeutics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Church & Dwight
  • 7.2: GSK
  • 7.3: Pfizer
  • 7.4: Sun Pharmaceutical
  • 7.5: Takeda Pharmaceutical
  • 7.6: F. Hoffmann-La Roche
  • 7.7: CELGENE Corporation